Benjamin F. Edwards & Company’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-700
Closed -$19K 1720
2020
Q4
$19K Buy
+700
New +$18K ﹤0.01% 1161
2019
Q2
Sell
-220
Closed -$1K 1958
2019
Q1
$1K Buy
+220
New +$1.39K ﹤0.01% 1655
2015
Q3
Sell
-579
Closed -$20K 1179
2015
Q2
$20K Sell
579
-266
-31% -$8.96K ﹤0.01% 781
2015
Q1
$29K Buy
845
+118
+16% +$4.11K 0.01% 675
2014
Q4
$26K Sell
727
-59
-8% -$1.99K 0.01% 624
2014
Q3
$26K Buy
+786
New +$26.7K 0.01% 608

Other funds holding ACH

Benjamin F. Edwards & Company's ACH Position: Q1 2021 in Review

Benjamin F. Edwards & Company sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 700 shares — an estimated $19K sold.

Benjamin F. Edwards & Company first reported a position in ACH in Q3 2014 and held it in 6 quarters. The position peaked at $29K in Q1 2015. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.

  • Benjamin F. Edwards & Company reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 700 Accendra Health shares in Q1 2021, an estimated $19K.
  • Benjamin F. Edwards & Company first reported a position in Accendra Health in Q3 2014 and held it in 6 quarters.
  • Benjamin F. Edwards & Company's Accendra Health position peaked at $29K in Q1 2015.
  • 253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2021, filed 14 May 2021.